Webcasts
Tuesday, October 11, 2022 at 11 AM EDT Learn about best practices in Host Cell Protein (HCP) assay development and qualification. Improve your understanding of the advanced orthogonal methods used to fully characterize HCPs in your process
Register Free: https://www.biopharminternational.com/bp/integration
Event Overview:
A well-developed and broadly reactive host cell protein (HCP) Enzyme-Linked Immunosorbent Assay (ELISA) is a sensitive and specific method used during the purification process of biologics to ensure removal of HCPs and to demonstrate process consistency and final drug substance purity. Regulatory guidelines require that sponsors use orthogonal methods for demonstrating antibody coverage to individual HCPs and provide a comprehensive assay qualification package to ensure the HCP ELISA is fit for purpose.
In this webinar, a Cygnus Technologies expert will discuss:
Key Learning Objectives:
Who Should Attend:
Speaker
John Locklear
Technical Services Manager
Cygnus Technologies
As a technical services manager, John Locklear leads technical support for Cygnus Technologies customers worldwide. Since joining Cygnus Technologies’ R&D department in 2011, Locklear developed many generic and custom HCP ELISA assays for several mammalian, yeast, and bacterial cell culture platforms as well as several host cell DNA assays. Locklear received a B.S. in biotechnology from the University of North Carolina at Pembroke.
Register Free: https://www.biopharminternational.com/bp/integration